Progressive multifocal leukoencephalopathy in multiple myeloma
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by reactivation of the JC virus in the context of immune suppression such as HIV, malignancy, and certain immunomodulatory medications. PML has been reported only rarely in multiple myeloma patients, and its presenting features and natural history in this population are not well known. We describe six cases of PML among multiple myeloma patients treated at our institution between 2013 and 2022, including two that developed on or shortly after treatment with recently developed BCMA-directed immunotherapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:110 |
|---|---|
| Enthalten in: |
European journal of haematology - 110(2023), 3 vom: 05. März, Seite 322-329 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hoeynck, Brian W [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 03.02.2023 Date Revised 03.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ejh.13909 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349775222 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349775222 | ||
| 003 | DE-627 | ||
| 005 | 20231226043428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ejh.13909 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1165.xml |
| 035 | |a (DE-627)NLM349775222 | ||
| 035 | |a (NLM)36465014 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hoeynck, Brian W |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Progressive multifocal leukoencephalopathy in multiple myeloma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2023 | ||
| 500 | |a Date Revised 03.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by reactivation of the JC virus in the context of immune suppression such as HIV, malignancy, and certain immunomodulatory medications. PML has been reported only rarely in multiple myeloma patients, and its presenting features and natural history in this population are not well known. We describe six cases of PML among multiple myeloma patients treated at our institution between 2013 and 2022, including two that developed on or shortly after treatment with recently developed BCMA-directed immunotherapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a multiple myeloma | |
| 650 | 4 | |a progressive multifocal leukoencephalopathy | |
| 700 | 1 | |a Cohen, Adam D |e verfasserin |4 aut | |
| 700 | 1 | |a Stadtmauer, Edward A |e verfasserin |4 aut | |
| 700 | 1 | |a Susanibar-Adaniya, Sandra P |e verfasserin |4 aut | |
| 700 | 1 | |a Vogl, Dan T |e verfasserin |4 aut | |
| 700 | 1 | |a Waxman, Adam J |e verfasserin |4 aut | |
| 700 | 1 | |a Bardsley, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Le, Samantha |e verfasserin |4 aut | |
| 700 | 1 | |a LaMaestra, Lexis |e verfasserin |4 aut | |
| 700 | 1 | |a Garfall, Alfred L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of haematology |d 1990 |g 110(2023), 3 vom: 05. März, Seite 322-329 |w (DE-627)NLM01261727X |x 1600-0609 |7 nnns |
| 773 | 1 | 8 | |g volume:110 |g year:2023 |g number:3 |g day:05 |g month:03 |g pages:322-329 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ejh.13909 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 110 |j 2023 |e 3 |b 05 |c 03 |h 322-329 | ||